Eucomed MedTech Forum 2010: EU team needed to analyse clinical investigations?
This article was originally published in RAJ Devices
Should the European Commission create a structure whereby a high-level team of clinical and technical experts analyses a manufacturer's application for clinical investigation for a given medical device? And should such a procedure replace the current system where a single competent authority reviews the application nationally with the support of an ethics committee?
You may also be interested in...
While the EU has selected the CND system as the basis for its nomenclature, GMDN is becoming increasingly valued on the US and international scene. How does it see its latest role panning out globally?
Updated medtech notified body figures from the European Commission always make headline news. But industry needs to see real appointments now, not a list of tricky-to-understand numbers.
Erik Hansson remains deputy head of devices in a move to the European Commission’s DG Sante from DG Grow. He now answers to a newly appointed devices head who shares a common educational background but whose recent pharmaceutical role may unsettle the devices industry.